Reflecting on our progress of our ESG priorities in 2022, we further advanced our environmental and philanthropic efforts while also continuing to strengthen our company culture. During the year, we continued to advance our environmental sustainability roadmap, reducing our carbon emissions and finalizing significant power purchasing agreements to accelerate our transitions towards a 100% renewable energy. Looking forward, we've also increased our 2030 greenhouse gas emissions reduction target to achieve a ...

Thermo Fisher Scientific Inc. (NYSE:TMO) 41st Annual J.P. Morgan Healthcare Conference January 10, 2023 10:30 AM ET Company Participants Marc Casper - Chairman, President and Chief Executive Officer Conference Call Participants Rachel Vatnsdal - JP Morgan Operator Rachel Vatnsdal Good morning, everyone. This is Rachel Vatnsdal from the Life Science Tools and Diagnostics team from JP Morgan. I'm joined today by Marc Casper, CEO of Thermo Fisher Scientific. So today will be a 40-minute presentation. We'll sta ...

41st Annual J.P. Morgan Healthcare Conference Marc N. Casper Chairman, President and Chief Executive Officer January 10th, 2023 The world leader in serving science 1 Safe Harbor / Non-GAAP Measures Various remarks that we may make in the following presentations about the company's future expectations, plans and prospects constitute forwardlooking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995, including statements about future revenue, financ ...

Thermo Fisher Scientific Inc. (NYSE:TMO) Q3 2022 Earnings Conference Call October 26, 2022 8:30 AM ET Company Participants Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, President and Chief Executive Officer Stephen Williamson - Senior Vice President and Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Research Derik De Bruin - Bank of America Patrick Donnelly - Citi Vijay Kumar - Evercore ISI Dan Brennan - Cowen Rachel Vatnsdal - JPMorgan Dan Arias - St ...

Thermo Fisher Scientific Inc. (NYSE:TMO) Q2 2022 Earnings Conference Call July 28, 2022 8:30 AM ET Company Participants Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, President and Chief Executive Officer Stephen Williamson - Senior Vice President and Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Research Patrick Donnelly - Citi Mike Ryskin - Bank of America Rachel Vatnsdal - JPMorgan Matt Sykes - Goldman Sachs Dan Arias - Stifel Puneet Souda - SVB Se ...

Thermo Fisher Scientific Inc. (NYSE:TMO) Q1 2022 Earnings Conference Call April 28, 2022 8:30 AM ET Company Participants Rafael Tejada – Vice President, Investor Relations Marc Casper – Chairman, President, and Chief Executive Officer Stephen Williamson – Senior Vice President and Chief Financial Officer Conference Call Participants Jack Meehan – Nephron Research Patrick Donnelly – Citi Derik De Bruin – Bank of America Tejas Savant – Morgan Stanley Vijay Kumar – Evercore Puneet Souda – SVB Leerink Securitie ...

Thermo Fisher Scientific Inc. (NYSE:TMO) Q4 2021 Earnings Conference Call February 2, 2022 8:30 AM ET Company Participants Rafael Tejada – Vice President-Investor Relations Marc Casper – Chairman, President and Chief Executive Officer Stephen Williamson – Senior Vice President and Chief Financial Officer Conference Call Participants Jack Meehan – Nephron Research Patrick Donnelly – Citi Dan Arias – Stifel Derik De Bruin – Bank of America Luke Sergott – Barclays Vijay Kumar – Evercore Dan Brennan – Cowen Tej ...

40th Annual J.P. Morgan Option 2 Healthcare Conference Marc N. Casper Chairman, President and Chief Executive Officer January 11, 2022 The world leader in serving science Safe Harbor / Non-GAAP Measures Various remarks that we may make in the following presentation about the company's future expectations, plans and prospects constitute forwardlooking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995, including statements about future revenue, fi ...